|
1
|
Sa-Nguanraksa D, Chuangsuwanich T,
Pongpruttipan T and O-Charoenrat P: High vascular endothelial
growth factor gene expression predicts poor outcome in patients
with non-luminal A breast cancer. Mol Clin Oncol. 3:1103–1108.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sa-Nguanraksa D, Sasanakietkul T,
O-Charoenrat C, Kulprom A and O-Charoenrat P: Gail model
underestimates breast cancer risk in thai population. Asian Pac J
Cancer Prev. 20:2385–2389. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
He L, Du Z, Xiong X, Ma H, Zhu Z, Gao H,
Cao J, Li T, Li H, Yang K, et al: Targeting androgen receptor in
treating HER2 positive breast cancer. Sci Rep.
7(14584)2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hickey TE, Robinson JL, Carroll JS and
Tilley WD: Minireview: The androgen receptor in breast tissues:
Growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol.
26:1252–1267. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rahim B and O'Regan R: AR signaling in
breast cancer. Cancers (Basel). 9(E21)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hu R, Dawood S, Holmes MD, Collins LC,
Schnitt SJ, Cole K, Marotti JD, Hankinson SE, Colditz GA and Tamimi
RM: Androgen receptor expression and breast cancer survival in
postmenopausal women. Clin Cancer Res. 17:1867–1874.
2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Peters AA, Buchanan G, Ricciardelli C,
Bianco-Miotto T, Centenera MM, Harris JM, Jindal S, Segara D, Jia
L, Moore NL, et al: Androgen receptor inhibits estrogen
receptor-alpha activity and is prognostic in breast cancer. Cancer
Res. 69:6131–6140. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rampurwala M, Wisinski KB and O'Regan R:
Role of the androgen receptor in triple-negative breast cancer.
Clin Adv Hematol Oncol. 14:186–193. 2016.PubMed/NCBI
|
|
9
|
Jiang HS, Kuang XY, Sun WL, Xu Y, Zheng
YZ, Liu YR, Lang GT, Qiao F, Hu X and Shao ZM: Androgen receptor
expression predicts different clinical outcomes for breast cancer
patients stratified by hormone receptor status. Oncotarget.
7:41285–41293. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sutton LM, Cao D, Sarode V, Molberg KH,
Torgbe K, Haley B and Peng Y: Decreased androgen receptor
expression is associated with distant metastases in patients with
androgen receptor-expressing triple-negative breast carcinoma. Am J
Clin Pathol. 138:511–516. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Naderi A and Hughes-Davies L: A
functionally significant cross-talk between androgen receptor and
ErbB2 pathways in estrogen receptor negative breast cancer.
Neoplasia. 10:542–548. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chia KM, Liu J, Francis GD and Naderi A: A
feedback loop between androgen receptor and ERK signaling in
estrogen receptor-negative breast cancer. Neoplasia. 13:154–166.
2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Robinson JL, Macarthur S, Ross-Innes CS,
Tilley WD, Neal DE, Mills IG and Carroll JS: Androgen receptor
driven transcription in molecular apocrine breast cancer is
mediated by FoxA1. EMBO J. 30:3019–3027. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Feng C, Neumeister V, Ma W, Xu J, Lu L,
Bordeaux J, Maihle NJ, Rimm DL and Huang Y: Lin28 regulates HER2
and promotes malignancy through multiple mechanisms. Cell Cycle.
11:2486–2494. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Shen H, Yang Y, Zhao L, Yuan J and Niu Y:
Lin28A and androgen receptor expression in ER-/Her2+ breast cancer.
Breast Cancer Res Treat. 156:135–147. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shen H, Zhao L, Feng X, Xu C, Li C and Niu
Y: Lin28A activates androgen receptor via regulation of c-myc and
promotes malignancy of ER-/Her2+ breast cancer. Oncotarget.
7:60407–60418. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Viswanathan SR, Powers JT, Einhorn W,
Hoshida Y, Ng TL, Toffanin S, O'Sullivan M, Lu J, Phillips LA,
Lockhart VL, et al: Lin28 promotes transformation and is associated
with advanced human malignancies. Nat Genet. 41:843–848.
2009.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Viswanathan SR and Daley GQ: Lin28: A
microRNA regulator with a macro role. Cell. 140:445–449.
2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang J, Bennett BD, Luo S, Inoue K, Grimm
SA, Schroth GP, Bushel PR, Kinyamu HK and Archer TK: LIN28A
modulates splicing and gene expression programs in breast cancer
cells. Mol Cell Biol. 35:3225–3243. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Balzeau J, Menezes MR, Cao S and Hagan JP:
The LIN28/let-7 pathway in cancer. Front Genet.
8(31)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Micello D, Marando A, Sahnane N, Riva C,
Capella C and Sessa F: Androgen receptor is frequently expressed in
HER2-positive, ER/PR-negative breast cancers. Virchows Arch.
457:467–476. 2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Park S, Koo J, Park HS, Kim JH, Choi SY,
Lee JH, Park BW and Lee KS: Expression of androgen receptors in
primary breast cancer. Ann Oncol. 21:488–492. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ni M, Chen Y, Lim E, Wimberly H, Bailey
ST, Imai Y, Rimm DL, Liu XS and Brown M: Targeting androgen
receptor in estrogen receptor-negative breast cancer. Cancer Cell.
20:119–131. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pietri E, Conteduca V, Andreis D, Massa I,
Melegari E, Sarti S, Cecconetto L, Schirone A, Bravaccini S, Serra
P, et al: Androgen receptor signaling pathways as a target for
breast cancer treatment. Endocr Relat Cancer. 23:R485–498.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Nguyen LH and Zhu H: Lin28 and let-7 in
cell metabolism and cancer. Transl Pediatr. 4:4–11. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lei XX, Xu J, Ma W, Qiao C, Newman MA,
Hammond SM and Huang Y: Determinants of mRNA recognition and
translation regulation by Lin28. Nucleic Acids Res. 40:3574–3584.
2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ni M, Chen Y, Fei T, Li D, Lim E, Liu XS
and Brown M: Amplitude modulation of androgen signaling by c-MYC.
Genes Dev. 27:734–748. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mayr F and Heinemann U: Mechanisms of
Lin28-mediated miRNA and mRNA regulation-a structural and
functional perspective. Int J Mol Sci. 14:16532–16553.
2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tsialikas J and Romer-Seibert J: LIN28:
Roles and regulation in development and beyond. Development.
142(2397)2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Thammaiah CK and Jayaram S: Role of let-7
family microRNA in breast cancer. Noncoding RNA Res. 1:77–82.
2016.PubMed/NCBI View Article : Google Scholar
|
